Hurley Capital LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

Hurley Capital LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 440 shares of the financial services provider’s stock, valued at approximately $59,000.

Several other institutional investors and hedge funds have also bought and sold shares of IBB. HHM Wealth Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares during the last quarter. VSM Wealth Advisory LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $30,000. Bradley & Co. Private Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $32,000. Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at $34,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $117.16 on Friday. The firm has a market capitalization of $5.27 billion, a PE ratio of 24.21 and a beta of 0.82. iShares Biotechnology ETF has a 52-week low of $117.02 and a 52-week high of $150.57. The firm has a fifty day moving average of $134.95 and a 200 day moving average of $138.11.

iShares Biotechnology ETF Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were issued a $0.1212 dividend. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.